NFKB1 and type 2 diabetes mellitus: In consistent with these previous findings, our study showed that the nuclear expression of transcriptional regulatory protein NF-κB, as a marker for activation of NF-κB signaling pathway, correlates with the severity of DN in patients with type 2 diabetes.